Rapidly Adaptable Rapid Test Platforms 

Develop rapid test platforms that can be reconfigured within days or weeks for emerging pathogens, enabling quick self-testing during a pandemic. Address the limitations of traditional lateral flow tests—which rely on antibodies and take months to develop—by significantly accelerating the deployment of diagnostic tools.